Recently, however, a large, international, multicenter RCT (the ELFIN trial) (ELFIN Trial Investigators Group, 2019) involving 2182 preterm infants has been published, which concluded that enteral supplementation with bovine lactoferrin did not reduce the risk of late-onset infection in very preterm infants. Here, LTF is linked to infection.